A Review on MERS-CoV, The Coronavirus Linked to Middle Eastern Respiratory illness Dhadwal Avantika*, Rana Ankita, Sharma Sakshi, Bhardwaj Gaurav Department of Pharmaceutics, Himachal Institute of Pharmaceutical Education and Research, Nadaun, Himachal Pradesh, India *Corresponding Author E-mail: ranaavantika270@gmail.com
Online Published on 23 April, 2025. Abstract Middle Eastern respiratory syndromes (MERS-CoV) are a novel coronavirus discovered in Saudi Arabia in 2012, with several outbreaks connected to the Arabian Peninsula. The virus has a high fatality rate and no effective antiviral medication or vaccination. It is known to spread mainly among bats and mammals, with close contact being the most likely way to spread the disease. MERS-CoV, SARS-CoV, and SARS-CoV-2 are all initially transmitted via mammals to humans. Medications like Lopinavir and ritonavir are used to treat COVID-19 caused by SARS-CoV-2. Lopinavir inhibits the HIV-1 protease enzyme, promoting the formation of immature virus particles. Acyclovir is used to treat acute herpetic keratitis, varicella zoster, viral labialis, and herpes labialis, while Ribavirin is used to treat hemorrhagic fever caused by viruses and hepatitis C. Chloroquine, a synthetic guanosine nucleoside, was removed from FDA authorization for emergency therapy for COVID-19 in June 2020. It inhibits heme to hemozoin transformation in malarial trophozoites, destroying the parasite when harmful heme levels in Plasmodium species grow. Chloroquine is used to avoid and cure malaria, treats extra intestinal amebiasis, and in some hospitalized individuals for COVID-19 coronavirus treatment. To ensure safety, visitors should wash their hands before and after touching animals and avoid handling dromedary camels, consuming uncooked meat, or consuming camel milk or urine. Top Keywords MERS-COV, COVID-19, Lopinavir, Acyclovir, Ribavirin, Chloroquine, Dromendry Camels. Top |